Johnson & Johnson vs. Silence Therapeutics Plc American Depository Share
JNJ
Johnson & Johnson
$273.41 +0.85%
VS SLNSilence Therapeutics Plc American Depository Share
$13.61 -3.48%
Johnson & Johnson (JNJ) comes out ahead, leading on 7 of 8 compared factors.
Size & Scale
| JNJ | SLN | |
|---|---|---|
| Market Cap | $653.35 billion | $845.92 million |
| Revenue (TTM) | $97.93 billion | $615,000 |
| Net Income (TTM) | $21.04 billion | $-59,953,000 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | SLN | |
|---|---|---|
| P/E Ratio | 31.72 | — |
| Price / Book | 7.69 | 21.99 |
| Price / Sales | 6.67 | 1375.47 |
JNJ leads on 2 of 2 valuation factors.
Profitability
| JNJ | SLN | |
|---|---|---|
| Net Margin | 21.48% | -9748.46% |
| Return on Equity | 24.76% | -155.84% |
JNJ leads on 2 of 2 profitability factors.
Dividend
| JNJ | SLN | |
|---|---|---|
| Dividend Yield | 1.96% | — |
| Payout Ratio | 62.18 | — |
JNJ and SLN split the dividend factors evenly.
Risk & Sentiment
| JNJ | SLN | |
|---|---|---|
| Short Interest | 0.67% | 0.00% |
SLN leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, SLN overview, SLN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.